AIMECS 07 (6th AFMC Symposium)

17.3.2013

It's been a great honour for us to be with you in the AIMECS 07, the 6th International Medicinal Chemistry Symposium organized by the Asian Federation of Medicinal Chemistry (AFMC), held in Istanbul-Turkey from July 08-11, 2007.

The 6th AFMC International Medicinal Chemistry Symposium has gathered the medicinal chemists from all over the world by the contribution of the European Federation of Medicinal Chemistry (EFMC) and the American Chemical Society Division of Medicinal Chemistry (ACSMC) as the participating organizations within this World Summit in Istanbul, the city that bridges the two great continents Asia and Europe.

Ismail YALCIN
(Symposium Chairman)
Esin AKI (SENER)
(Organizing Committee Chair)


Total number of participation to the AIMECS 07 was 441. Participants were from 42 different countries all over the world. These countries were China, Hong Kong, Indenosia, India, Iran, Iraq, Israel, Japan, Korea, Kyrgyztan, Singapore, Taiwan, Thailand from Asia; Belgium, Crotia, Czech Republic, England, France, Germany, Greece, Holland, Hungary, Italy, Latvia, Poland, Portugal, Romania, Russia, Spain, Sweden, Switzerland, Ukraine from the continent Europe; Algeria, Cameroon, Egypt, Ghana, Nigeria, South Africa from Africa; Canada, USA, Brazil from America; Australia from Ocenia and Turkey, a bridge between two continents, from both Europe and Asia as the host country.

Distribution of the Participants: 

220 from ACADEMIA, 50 %
95 from INDUSTRY, 21.5 %
126 as STUDENTS, 28.5 % 

Click on the AIMECS 07 Group Picture to enlarge it
...Click on the AIMECS 07 Group Picture to enlarge it...

Opening Lecture: “Strategy-Life Cycle Management of Drugs” by Toshi-Hiko KOBAYASHI, AFMC Past President, PhRMA (USA), Japan

Syposium Web Site: www.aimecs07.org


Organizing Committee
Chair:Esin Aki (Sener) (AFMC, Turkey)
Members:

Toshi-hiko Kobayashi (AFMC, Japan)
David A. Winkler (AFMC, Australia)
Ferran Sanz (EFMC, Spain)
Muharrem Olcer (AFMC, Turkey)
Ilkay Yildiz (AFMC, Turkey)
Ozlem Temiz-Arpaci (AFMC, Turkey)
Betul Tekiner-Gulbas (AFMC, Turkey)


Scientific Advisory Board
  • David Alker (EFMC, UK)
  • Oznur Ates (Turkey)
  • Altan Bilgin (Turkey)
  • Moon-Ho Chang (Korea)
  • Fener Chen (China)
  • Mary Collins (Australia)
  • Ercin Erciyas (Turkey)
  • Mevlut Ertan (Turkey)
  • Nobutaka Fujii (Japan)
  • Toshio Fujita (Japan)
  • Athina Gerinokaki (Greece)
  • Renate Griffith (Australia)
  • Zongru Guo (China)
  • Aysel Gursoy (Turkey)
  • Shunichi Hashimoto (Japan)
  • Koichi Hirai (Japan)
  • Reuben Jih-Ru Hwu (Taiwan)
  • Sang-Hun Jung (Korea)
  • Yong Sup Lee (Korea)
  • Norio Matsuki (Japan)
  • Tetsuo Nagano (Japan)
  • Shigenori Ohkawa (Japan)
  • Sumru Ozkirimli (Turkey)
  • Tom Perun (ACS, USA)
  • Sevim Rollas (Turkey)
  • Dave Rotella (ACS, USA)
  • Masakatsu Shibasaki (Japan)
  • Teruo Takayanagi (Japan)
  • Hideo Utsumi (Japan)
  • Dali Yin (China)
  • Peter Wipf (ACS, USA)
  • Li-He Zhang (China)
AIMECS 07 Organized by Asian Federation for Medicinal Chemistry

  The Pharmaceutical Society of Japan (PSI)
  The Chemical Society of Japan (CSI)
  Japan Society for Bioscience, Biotechnology and Agrochemistry (JSBBA)
  The Society of Synthetic Organic Chemistry, Japan (SSOCJ)
  The Pharmaceutical Society of Korea (PSK)
  The Korean Chemical Society (KCS)
  Chinese Pharmaceutical Association (CPA)
  China Pharmaceutical Industry Association (CPIA)
  The Royal Australian Chemical Institute (RACI)
  Chemical Society Located in Taipei (CSLT)
  The Computer Aided Drug Design & Development Society in Turkey (CADD&D)

Managed by

  The Computer Aided Drug Design & Development Society in Turkey (CADD&D)

Participating Organizations

  European Federation for Medicinal Chemistry (EFMC)
  American Chemical Society, Division of Medicinal Chemistry (ACSMC)

Sponsored by

  The International Union of Pure and Applied Chemistry (IUPAC)
  The Scientific and Technological Research Council of Turkey (TUBITAK)

Plenary Lecturers

  Masakatsu SHIBASAKI, The University of Tokyo, Japan
  Colin WARD, CSIRO Molecular&Health Technologies, Australia
  Johann GASTEIGER, Computer-Chemie-Centrum, Germany

Invited Lecturers

  Raymond J. ANDERSEN, University of British Columbia Vancouver, Canada
  Patrick CHENE, Novartis, Switzerland
  Alex TROPSHA, University of North Carolina at Chapel Hill, USA
  Hajime OHIGASHI, Kyoto University, Japan
  Hisayoshi MORIAOKA, Ministry of Health, Labour and Welfare, Japan
  Lak Shin JEONG, Ewha Womans University, Korea
  Kazuei IGARASHI, Chiba University, Japan
  Victor KARTSEV, InterBioScreen, Russia
  Peter HENDERSON, University of Leeds, UK
  Nobutaka FUJII, Kyoto University, Japan
  Frank E. BLANEY, Computational&Structural Chemistry, UK
  Soon Kil AHN, Chong Kun Dang Research Institute, Korea

Oral Presenters

  Jose A. SALAS, Oncologia del Principado de Asturias, Spain
  Jurgen ROHR, University of Kentucky, USA
  Ming-Qiang ZHANG, Biotica Technology Ltd., UK
  Frank E. KOEHN, Wyeth Research, New York, USA
  Mino CAIRA, University of Cape Town, South Africa
  Xavier BARRIL, Barcelona University, Spain
  Turkan HALILOGLU, Bogazici University, Turkey
  Alessio CIULLI, University of Cambridge, UK
  Ichio SHIMADA, University of Tokyo, Japan
  Massimiliano BONOMI, Computational Science, Switzerland
  Maurizio BOTTA, Dipartimento Farmaco Chimico Tecnologico, Italy
  Gregory J. TAWA, Wyeth Research, USA
  Ilkay YILDIZ, Ankara University, Turkey
  Pietro COZZINI, University of Parma, Italy
  Bo Cheng WANG, Tamkang University, Taiwan
  Vladimir A. PALYULIN, Moscow State University, Russia
  Hirokazu KAWAGISHI, Shizuoka University, Japan
  Hiroshi TERADA, Tokyo University of Science, Japan
  Jonathan B. BAELL, The Walter and Eliza Hall Institute of Medical Research, Australia
  Yutaka EBIZUKA, University of Tokyo, Japan
  Jian-Yong WU, Hong Kong Polytechnic University, China
  Mark PAXTON, PhRMA, USA
  Michael J. CAINE, Australia
  Hulya CAYLI, Paragon Consultancy Incorporated, Turkey
  Sanghee KIM, Seoul National University, Korea
  Jae-Sang RYU, Ewha Womans University, Korea
  Moohi YOO, Dong-A Pharmaceutical Co., Korea
  Mao-Sheng CHENG, Shenyang Pharmaceutical University, China
  Yong-Chul KIM, Gwangju Institute of Science and Technology, Korea
  Tetsuo NAGANO, University of Tokyo, Japan
  Naoki UMEZAWA, Nagoya City University, Japan
  Norio MATSUKI, University of Tokyo, Japan
  David ARAGONES, Prous Institute for Biomedical Research, Spain
  Tomofumi SANTA,  University of Tokyo, Japan
  Jung-Mi HAH, Korea Institute of Science and Technology, Korea
  David Winkler, CSIRO Molecular&Health Technologies, Australia
  Jasbir Singh, deCODE Chemistry&Biostructures, Iceland
  Nino RUSSO, Universita della Calabria, Italy
  Yousef AL-ABED, Yale University, USA
  Vladimir POTEMKIN, Chelyabinsk State University, Russia
  Hermann LAGE, Institute of Pathology, Germany
  Renate GRIFFITH, University of Newcastle, Australia
  Tanil KOCAGOZ, Yeditepe University, Turkey
  Po-Huang LIANG, Academia Sinica, Taiwan
  NAgy MORSY, Osaka University, Japan
  Biing-Jiun UANG, National Tsing Hua University, Taiwan
  Tetsuro KIKUCHI, Otsuka Pharmaceutical Co. Ltd., Japan
  Yuusaku YOKOYAMA, Toho University, Japan
  Kunisuke IZAWA, Ajinomoto Co. Inc., Japan
  Dae-Kee KIM, Ewha Womans University, Korea
  Henry J. LEE, FLorida A&M University, USA
  Jih Ru HWU, National Tsing Hua University, Taiwan
  Thomas MAVROMOUSTAKOS, The National Hellenic Research Foundation, Germany
  Noritaka KURODA, Takeda Pharmaceutical Company Ltd., Japan
  Serdar KUYUCAK, University of Sydney, Australia
  Tomoyuki SAITO, University of Toyama, Japan
  Hsing-Pang HSIEH, National Health Research Institutes, Taiwan
  Seonggu RO, CrystalGenomics Inc., Korea
  Jang-Yang CHANG, National Health Research Institutes, Taiwan
  Aleem GANGJEE, Duquesne University, USA
  Alessandra MAGISTRATO, CNR-INFM, Italy
  Vasiliki VALLA, Aristotle University of Thessaloniki, Greece

Topics of the AIMECS 07 Symposium

Chemistry for pharmaceuticals
  New synthetic methods
  Process chemistry
  Biomimetics
  Chemical genomics

New drug targets
  Endogenous substances
  Receptors, enzymes, channels
  Glycoproteins
  Genomic pharmacology

ADME/Tox.
  Drug metabolism and toxicology
  Drug delivery
  Medicinal bioengineering
  Biomaterials

New methods for drug discovery
  Analytical & physico-pharmaceutical chemistry
  High-throughput medicinal & combinatorial advances
  Lead identification & optimization
  Glycotechnology

Predictive in silico methods
  Bioinformatics
  Structural biology for drug development
  Complex systems approaches
  Cheminformatics and QSAR
  Computational chemistry

Protein-Protein Interactions (EFMC Session)

Reversal of multi-drug resistance
  New Antibiotics
  New Antifungal Agents
  New Antiviral Agents

Natural products in drug discovery

Recent approaches in anticancer therapy

Biomarkers in HPS through clinical development

Intellectual Property (IP) and Regulatory affairs
  Patenting
  Clinical trials issues
  Registration issues
  Spinoffs and new businesses

The role and significance of Preclinical studies in drug development

Recent Innovations in the Development of Anti-tumor Natural Products (ACSMC Session)